Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1993 Mar;37(3):501–506. doi: 10.1128/aac.37.3.501

Pharmacokinetics of intravenous fusidic acid in patients with cholestasis.

J D Peter 1, F Jehl 1, T Pottecher 1, J P Dupeyron 1, H Monteil 1
PMCID: PMC187699  PMID: 8460918

Abstract

The pharmacokinetics of fusidic acid and 3-ketofusidic acid were investigated in cholestatic and noncholestatic patients after intravenous administration of single and multiple doses of 500 mg of sodium fusidate. The patients, all with low serum albumin levels, were divided into three groups. Group I consisted of six noncholestatic patients; group II consisted of nine mildly cholestatic patients with mild hepatic impairment (conjugated bilirubin, 47 mumol liter-1; alkaline phosphatase, 280 IU liter-1; gamma-glutamyltranspeptidase, 190 IU liter-1); group III consisted of six benign intrahepatic cholestatic patients with high isolated conjugated hyperbilirubinemia (98.1 mumol liter-1). Assays were performed by high-pressure liquid chromatography. At steady state, the mean peak concentrations in serum were 63.7, 44.9, and 92.2 micrograms ml-1 in groups I, II, and III, respectively; over a dosage interval, areas under the concentration-time curve were 411.1, 238.7, and 603.4 micrograms.h ml-1 and the mean body clearances were 0.34, 0.53, and 0.25 ml min kg-1 in groups I, II, and III, respectively. The accumulation ratio of fusidic acid increased from 2.8 and 2.4 in groups I and II to 4.2 in group III. At steady state, the ratios of the areas under the concentration-time curve from 0 to 8 h for 3-ketofusidic acid/fusidic acid were 0.11, 0.09, and 0.10 in the three groups, respectively. Only very small amounts of fusidic acid and 3-ketofusidic acid were found in urine. These results substantiate the following hypotheses. In group I and II patients the clearance is higher than that in healthy volunteers because of the increased free, unbound fraction of fusidic acid, a consequence of lower serum albumin concentrations, resulting in increased distribution in tissue and hepatic metabolism. In group III patients, the higher bilirubinemia results in competition with fusidic acid for the limited glucuronidation, thus compensating for the increased elimination with fusidic acid because of the low serum albumin concentration. These results suggest that fusidic acid can be administered normally even to patients with high bilirubinemia because the postoperative serum albumin concentration is usually low.

Full text

PDF
501

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. D. Fusidic acid: new opportunities with an old antibiotic. Can Med Assoc J. 1980 Apr 5;122(7):765–769. [PMC free article] [PubMed] [Google Scholar]
  2. Benhamou J. P. L'élévation de la gammaglutamyl-transpeptidase sérique. Une constatation de signification très variée. Presse Med. 1991 Jul 6;20(26):1201–1203. [PubMed] [Google Scholar]
  3. Bergeron M. G., Desaulniers D., Lessard C., Lemieux M., Després J. P., Métras J., Raymond G., Brochu G. Concentrations of fusidic acid, cloxacillin, and cefamandole in sera and atrial appendages of patients undergoing cardiac surgery. Antimicrob Agents Chemother. 1985 Jun;27(6):928–932. doi: 10.1128/aac.27.6.928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. ELEY A., HARGREAVES T., LAMBERT H. P. JAUNDICE IN SEVERE INFECTIONS. Br Med J. 1965 Jul 10;2(5453):75–77. doi: 10.1136/bmj.2.5453.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Evans C., Evans M., Pollock A. V. The incidence and causes of postoperative jaundice. A prospective study. Br J Anaesth. 1974 Jul;46(7):520–525. doi: 10.1093/bja/46.7.520. [DOI] [PubMed] [Google Scholar]
  6. Eykyn S. J. Staphylococcal bacteraemia and endocarditis and fusidic acid. J Antimicrob Chemother. 1990 Feb;25 (Suppl B):33–38. doi: 10.1093/jac/25.suppl_b.33. [DOI] [PubMed] [Google Scholar]
  7. FAHRLAENDER H., HUBER F., GLOOR F. INTRAHEPATIC RETENTION OF BILE IN SEVERE BACTERIAL INFECTIONS. Gastroenterology. 1964 Dec;47:590–599. [PubMed] [Google Scholar]
  8. GODTFREDSEN W. O., JAHNSEN S., LORCK H., ROHOLT K., TYBRING L. Fusidic acid: a new antibiotic. Nature. 1962 Mar 10;193:987–987. doi: 10.1038/193987a0. [DOI] [PubMed] [Google Scholar]
  9. Godtfredsen W. O., Vangedal S. On the metabolism of fusidic acid in man. Acta Chem Scand. 1966;20(6):1599–1607. doi: 10.3891/acta.chem.scand.20-1599. [DOI] [PubMed] [Google Scholar]
  10. Guenthner S. H., Wenzel R. P. In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1984 Aug;26(2):268–269. doi: 10.1128/aac.26.2.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Güttler F., Tybring L., Engberg-Pedersen H. Interaction of albumin and fusidic acid. Br J Pharmacol. 1971 Sep;43(1):151–160. doi: 10.1111/j.1476-5381.1971.tb07164.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Humble M. W., Eykyn S., Phillips I. Staphylococcal bacteraemia, fusidic acid, and jaundice. Br Med J. 1980 Jun 21;280(6230):1495–1498. doi: 10.1136/bmj.280.6230.1495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kutty K. P., Nath I. V., Kothandaraman K. R., Barrowman J. A., Perkins P. G., Ra M. U., Huang S. N. Fusidic acid-induced hyperbilirubinemia. Dig Dis Sci. 1987 Aug;32(8):933–938. doi: 10.1007/BF01296717. [DOI] [PubMed] [Google Scholar]
  14. Le Gall J. R., Loirat P., Alperovitch A., Glaser P., Granthil C., Mathieu D., Mercier P., Thomas R., Villers D. A simplified acute physiology score for ICU patients. Crit Care Med. 1984 Nov;12(11):975–977. doi: 10.1097/00003246-198411000-00012. [DOI] [PubMed] [Google Scholar]
  15. Menday A. P., Marsh B. T. Intravenous fusidic acid ('Fucidin') in the management of severe staphylococcal infections: a review of 46 cases. Curr Med Res Opin. 1976;4(2):132–138. doi: 10.1185/03007997609109293. [DOI] [PubMed] [Google Scholar]
  16. Portier H. A multicentre, open, clinical trial of a new intravenous formulation of fusidic acid in severe staphylococcal infections. J Antimicrob Chemother. 1990 Feb;25 (Suppl B):39–44. doi: 10.1093/jac/25.suppl_b.39. [DOI] [PubMed] [Google Scholar]
  17. Prandi D., Erlinger S., Roche-Sicot J., Husson J., Lortat-Jacob J. L. Cholestase intra-hépatique postopératoire bénigne. Nouv Presse Med. 1975 Sep 20;4(30):2165–2168. [PubMed] [Google Scholar]
  18. Reeves D. S. The pharmacokinetics of fusidic acid. J Antimicrob Chemother. 1987 Oct;20(4):467–476. doi: 10.1093/jac/20.4.467. [DOI] [PubMed] [Google Scholar]
  19. Schmid J., Ballowitz L. Fucidic acid in Gunn rats. No influence on serum bilirubin concentration. Arch Dis Child. 1979 Jul;54(7):566–567. doi: 10.1136/adc.54.7.566-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sørensen H. Liquid chromatographic determination of fusidic acid in serum. J Chromatogr. 1988 Sep 9;430(2):400–405. doi: 10.1016/s0378-4347(00)83177-1. [DOI] [PubMed] [Google Scholar]
  21. Taburet A. M., Guibert J., Kitzis M. D., Sorensen H., Acar J. F., Singlas E. Pharmacokinetics of sodium fusidate after single and repeated infusions and oral administration of a new formulation. J Antimicrob Chemother. 1990 Feb;25 (Suppl B):23–31. doi: 10.1093/jac/25.suppl_b.23. [DOI] [PubMed] [Google Scholar]
  22. Van der Auwera P., Godard C., Denis C., De Maeyer S., Vanhoof R. In vitro activities of new antimicrobial agents against multiresistant Staphylococcus aureus isolated from septicemic patients during a Belgian national survey from 1983 to 1985. Antimicrob Agents Chemother. 1990 Nov;34(11):2260–2262. doi: 10.1128/aac.34.11.2260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wise R., Pippard M., Mitchard M. The disposition of sodium fusidate in man. Br J Clin Pharmacol. 1977 Oct;4(5):615–619. doi: 10.1111/j.1365-2125.1977.tb00795.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES